These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9386194)

  • 61. Reversible myocardial dysfunction: basics and evaluation.
    Gowda RM; Khan IA; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2004 Dec; 97(3):349-53. PubMed ID: 15561318
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The pathology of hibernating myocardium.
    Berry GJ; Masek M
    Nucl Med Commun; 2002 Apr; 23(4):303-9. PubMed ID: 11930183
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles.
    Barnes E; Camici PG
    Heart; 1999 Oct; 82(4):535. PubMed ID: 10576916
    [No Abstract]   [Full Text] [Related]  

  • 64. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium.
    Vanoverschelde JL; Wijns W; Depré C; Essamri B; Heyndrickx GR; Borgers M; Bol A; Melin JA
    Circulation; 1993 May; 87(5):1513-23. PubMed ID: 8491006
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Assessing myocardial viability to help select patients for revascularization to improve left ventricular dysfunction due to coronary artery disease.
    Patterson RE; Pilcher WC
    Semin Thorac Cardiovasc Surg; 1995 Oct; 7(4):214-26. PubMed ID: 8590746
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Refractory heart failure. Myocardial revascularization as alternative to heart transplantation].
    Alfieri O; Mangia R
    Ital Heart J Suppl; 2002 Aug; 3(8):812-21. PubMed ID: 12407836
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Viable: yes, no, or somewhere in the middle?
    Beller GA; Budge LP
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1069-71. PubMed ID: 19761984
    [No Abstract]   [Full Text] [Related]  

  • 68. [The hibernating myocardium--its use in clinical practice].
    Knap J; Harrer J
    Cas Lek Cesk; 1997 Mar; 136(5):138-41. PubMed ID: 9221185
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Positron emission tomography for the assessment of myocardial viability: a synopsis of methods and indications.
    Lucignani G; Landoni C; Paolini G; Messa MC; Gilardi MC; Rossetti C; Fazio F
    Rays; 1999; 24(1):81-95. PubMed ID: 10358386
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Myocardial blood flow in patients with hibernating myocardium.
    Camici PG; Rimoldi OE
    Cardiovasc Res; 2003 Feb; 57(2):302-11. PubMed ID: 12566103
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Stunning, hibernation, and heart failure in patients with coronary disease: crucial role of impaired coronary flow reserve].
    Montano M; Camici PG
    Ital Heart J Suppl; 2003 Sep; 4(9):727-32. PubMed ID: 14635390
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Importance of diagnosing hibernating myocardium: how and in whom?
    Rahimtoola SH
    J Am Coll Cardiol; 1997 Dec; 30(7):1701-6. PubMed ID: 9385896
    [No Abstract]   [Full Text] [Related]  

  • 73. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial.
    D'Egidio G; Nichol G; Williams KA; Guo A; Garrard L; deKemp R; Ruddy TD; DaSilva J; Humen D; Gulenchyn KY; Freeman M; Racine N; Benard F; Hendry P; Beanlands RS;
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1060-8. PubMed ID: 19761983
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium.
    Fallavollita JA; Perry BJ; Canty JM
    Circulation; 1997 Apr; 95(7):1900-9. PubMed ID: 9107179
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction.
    Fath-Ordoubadi F; Pagano D; Marinho NV; Keogh BE; Bonser RS; Camici PG
    Am J Cardiol; 1998 Jul; 82(1):26-31. PubMed ID: 9671004
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Metabolic changes in hibernating myocardium after percutaneous transluminal coronary angioplasty and the relation between recovery in left ventricular function and free fatty acid metabolism.
    Shimonagata T; Nanto S; Kusuoka H; Ohara T; Inoue K; Yamada S; Nishimura Y; Matsubara N; Hori M; Nishimura T; Kubori S
    Am J Cardiol; 1998 Sep; 82(5):559-63. PubMed ID: 9732879
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Hibernating myocardium--a reality?].
    Sousa AG
    Rev Assoc Med Bras (1992); 1997; 43(2):89-90. PubMed ID: 9336040
    [No Abstract]   [Full Text] [Related]  

  • 78. The role of neurohormonal antagonists in hibernating myocardium.
    Lahiri A; Senior R; Khattar R
    J Cardiovasc Pharmacol; 1999 Jun; 33 Suppl 3():S9-16. PubMed ID: 10442680
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The hibernating myocardium an its recognition].
    Spósito AC; Chagas AC; Da Luz PL
    Rev Assoc Med Bras (1992); 1997; 43(2):154-62. PubMed ID: 9336052
    [No Abstract]   [Full Text] [Related]  

  • 80. Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium".
    Braunwald E; Rutherford JD
    J Am Coll Cardiol; 1986 Dec; 8(6):1467-70. PubMed ID: 3782649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.